EYE 2.70% 19.0¢ nova eye medical limited

Just looking at the i-track advance device, it appears to me...

  1. 206 Posts.
    lightbulb Created with Sketch. 10

    Just looking at the i-track advance device, it appears to me that competitors should be able to come up with device of same functionality and ease of use within a year and get approved. The share prices seem to be pricing in this possibility. The speed at which i-track advance gain market share will determine i-tracks advance future, because in a years time it will be a different competitive scene.
    How strong is EYE's patents on i-track advance?
    Any thoughts or comments?
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.